Understanding malignant transformation of precancerous lesions in human colon
TRANSFORMATION aims to uncover the dynamic evolution of human colon tumors from benign to malignant states using organoid models and paired biopsies to reveal mutation patterns and environmental influences.
Projectdetails
Introduction
A crucial milestone in tumor progression is the transformation from a benign adenoma to a malignant cancer, which has a profound impact on clinical outcome and therapy design. Despite its importance, it is poorly understood why it manifests itself as a bottleneck that can restrain precancerous adenomas for years.
Challenges in Understanding Tumor Evolution
While recent sequencing efforts inform ‘static’ insights into the status of cancer genomes, these are incomplete to infer how they evolved, assess the functional consequence of mutations, nor how much malignancy is environmentally instructed.
Practical limitations hamper scientific advancement into the dynamic nature of tumor evolution. Foremost, studying human tumor evolution is challenging as sequential sampling is not feasible, and pre-malignant events that may hold the clue for understanding transformation often occur years before cancer diagnosis. Moreover, experimental models that reflect malignant transformation, let alone of human origin, are lacking.
Project Overview
TRANSFORMATION aims to resolve how human cancer genomes evolve towards malignancy, and its role in triggering malignancy.
Research Approach
To gain new insights on this matter, TRANSFORMATION takes a unique approach to produce experimental insights into evolutionary parameters that are inherently dynamic in nature and cannot be obtained from tumor sequencing alone.
- Using paired biopsies from early-stage colon cancers, I generated unique organoid models from pre- and post-transformation regions.
- Together with in situ analysis of matched tumors, TRANSFORMATION will reveal:
- The elusive rate and order by which mutations and copy-number alterations are acquired.
- The patterns by which cancer karyotypes evolve.
- Dissecting functional from non-functional genetic heterogeneity on tumor phenotypes.
- Investigating possible selection pressures imposed by environmental conditions.
Conclusion
TRANSFORMATION will solve how colon tumors evolve pre-malignancy, which properties promote malignancy, and why transformation is an evolutionary bottleneck.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.998.750 |
Totale projectbegroting | € 1.998.750 |
Tijdlijn
Startdatum | 1-5-2024 |
Einddatum | 30-4-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITAIR MEDISCH CENTRUM UTRECHTpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Probing the malignant potential of mutant clones in healthy mammary tissue by successive mutagenesisSUCCESSion aims to develop a novel gene editing technology to study the impact of mutation order on pre-cancer evolution and environment rewiring, enhancing understanding and early intervention strategies for cancer. | ERC Starting... | € 1.497.740 | 2024 | Details |
Tracing the origin of clonal pathogenesisThis project aims to uncover how mutant clones in epithelial cancers evade protection mechanisms through genetic tracing and advanced genomics, potentially leading to new cancer prevention and treatment strategies. | ERC Synergy ... | € 9.936.185 | 2025 | Details |
High throughput phylogeography of tumors: how the tissue environment influences cancer evolution?This project aims to develop transcriptional phylogeography to study tumor evolution in situ at single-cell resolution, linking tumor microenvironment characteristics to sub-clonal properties. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Giant-leaps during tumorigenesis: Dissecting saltatory evolution in cancer ‘in the making’This project aims to develop an AI-driven framework to study saltatory evolution events in colorectal cancer by analyzing nuclear atypias and their role in tumorigenesis and therapy resistance. | ERC Advanced... | € 3.428.458 | 2024 | Details |
Dynamics of Adaptation and Resistance in Cancer: MApping and conTrolling Transcriptional and Epigenetic RecurrenceThis project aims to uncover the mechanisms of drug resistance in colorectal cancer through innovative models and computational methods, ultimately improving treatment strategies and patient outcomes. | ERC Consolid... | € 1.995.582 | 2024 | Details |
Probing the malignant potential of mutant clones in healthy mammary tissue by successive mutagenesis
SUCCESSion aims to develop a novel gene editing technology to study the impact of mutation order on pre-cancer evolution and environment rewiring, enhancing understanding and early intervention strategies for cancer.
Tracing the origin of clonal pathogenesis
This project aims to uncover how mutant clones in epithelial cancers evade protection mechanisms through genetic tracing and advanced genomics, potentially leading to new cancer prevention and treatment strategies.
High throughput phylogeography of tumors: how the tissue environment influences cancer evolution?
This project aims to develop transcriptional phylogeography to study tumor evolution in situ at single-cell resolution, linking tumor microenvironment characteristics to sub-clonal properties.
Giant-leaps during tumorigenesis: Dissecting saltatory evolution in cancer ‘in the making’
This project aims to develop an AI-driven framework to study saltatory evolution events in colorectal cancer by analyzing nuclear atypias and their role in tumorigenesis and therapy resistance.
Dynamics of Adaptation and Resistance in Cancer: MApping and conTrolling Transcriptional and Epigenetic Recurrence
This project aims to uncover the mechanisms of drug resistance in colorectal cancer through innovative models and computational methods, ultimately improving treatment strategies and patient outcomes.